A doctor, a patient and a former federal official weigh in on Medicare’s recent move to restrict access to a new Alzheimer’s treatment.
Podcast
Posted inPublic Health
Winter Hiatus Episodes
Explore the guest and rerun episodes we featured in the Tradeoffs podcast feed during our winter 2021-2022 hiatus.
Posted inInsurance
Rethinking Telehealth’s Role in Treating Addiction
COVID opened the door to treating addiction remotely. Now policymakers have to decide whether to keep telehealth around.
Posted inCost of Care
Let’s Make a Deal…on Drug Prices
Democrats are on the brink of passing a historic set of drug price reforms. How will they impact patients, insurers and the drug industry?
Posted inInsurance
Has Medicaid Managed Care Delivered On Its Promise?
Letting private insurers offer Medicaid coverage was supposed to lower costs and improve care. Did it work?
Posted inInsurance
The Costly, Confusing Medicare Choices Facing 62 Million Americans
It’s Medicare open enrollment time, but shopping for a new plan is much harder and riskier than it seems.
Posted inWorkforce
COVID’s Push and Pull on the Public Health Workforce
A conversation between one person who felt she had to leave public health and another who was inspired to join the field.
Posted inHealth Law
Can Democrats Reconcile Their Health Policy Differences?
Democratic lawmakers face tough health care compromises as they struggle to secure votes for their blockbuster spending bill.
Posted inWorkforce
How Do We Keep the Nursing Shortage From Getting Worse?
Experts are worried the U.S. could be headed for its worst nursing shortage in 20 years.
Posted inInsurance
Inside Big Health Insurers’ Side Hustle
America’s largest health insurance companies moonlight as obscure middlemen, managing billions in health care spending for many of the country’s biggest employers.